Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Marco Moschini

Showing results (61-70 of 560) with videos related to

Pageof 56
Sort By:
International Braz J Urol : Official Journal of the Brazilian Society of Urology|October 19, 2019
Focal therapy for prostate cancer - index lesion treatment vs. hemiablation. A matter of definitionArmando Stabile, Marco Moschini, Francesco Montorsi, et al.
BMC Medicine|April 6, 2016
Incorporation of tissue-based genomic biomarkers into localized prostate cancer clinicsMarco Moschini, Martin Spahn, Agostino Mattei, et al.
European Urology Focus|July 21, 2017
Critical Review of Outcomes from Radical Cystectomy: Can Complications from Radical Cystectomy Be Reduced by Surgical Volume and Robotic Surgery?Marco Moschini, Giuseppe Simone, Arnulf Stenzl, et al.
Current Opinion in Urology|September 12, 2024
Perioperative platform for muscle-invasive bladder cancer trials: designs and endpointsEkaterina Laukhtina, Marco Moschini, Jeremy Yuen-Chun Teoh, et al.
Current Opinion in Urology|September 3, 2024
Bladder sparing options for muscle-invasive bladder cancerEkaterina Laukhtina, Marco Moschini, Jeremy Yuen-Chun Teoh, et al.
Minerva Urology and Nephrology|December 18, 2025
HUGO™ RAS for radical nephroureterectomy: a new platform facing an old challengeAndrea Mari, Simone Albisinni, Roberto Contieri, et al.
European Urology|August 1, 2024
Re: Jeremy Yuen-Chun Teoh, Cheung-Hing Cheng, Chiu-Fung Tsang, et al. Transurethral En Bloc Resection Versus Standard Resection of Bladder Tumour: A Randomised, Multicentre, Phase 3 Trial. Eur Urol. 2024;86:103-111Francesco Montorsi, Pietro Scilipoti, Alessandro Viti, et al.
The Prostate|January 26, 2018
Accuracy of standardized 12-core template biopsies versus non-standardized biopsies for detection of Epstein Grade 5 prostate cancer regarding the histology of the prostatectomy specimenChristoph Würnschimmel, Pietro Grande, Marco Moschini, et al.
The Journal of Urology|September 14, 2021
Contemporary Outcomes of Patients With Nonmuscle-Invasive Bladder Cancer Treated with Bacillus Calmette-Guérin: Implications for Clinical Trial Design. LetterFrancesco Montorsi, Marco Moschini, Andrea Necchi, et al.
Cancers|September 28, 2023
The Association between Lymph Node Dissection and Survival in Lymph Node-Negative Upper Urinary Tract Urothelial CancerAleksander Ślusarczyk, Piotr Zapała, Tomasz Piecha, et al.
Pageof 56

Showing results (61-70 of 560) with videos related to

Sort By:
Pageof 56
International Braz J Urol : Official Journal of the Brazilian Society of Urology|October 19, 2019
Focal therapy for prostate cancer - index lesion treatment vs. hemiablation. A matter of definitionArmando Stabile, Marco Moschini, Francesco Montorsi, et al.
BMC Medicine|April 6, 2016
Incorporation of tissue-based genomic biomarkers into localized prostate cancer clinicsMarco Moschini, Martin Spahn, Agostino Mattei, et al.
European Urology Focus|July 21, 2017
Critical Review of Outcomes from Radical Cystectomy: Can Complications from Radical Cystectomy Be Reduced by Surgical Volume and Robotic Surgery?Marco Moschini, Giuseppe Simone, Arnulf Stenzl, et al.
Current Opinion in Urology|September 12, 2024
Perioperative platform for muscle-invasive bladder cancer trials: designs and endpointsEkaterina Laukhtina, Marco Moschini, Jeremy Yuen-Chun Teoh, et al.
Current Opinion in Urology|September 3, 2024
Bladder sparing options for muscle-invasive bladder cancerEkaterina Laukhtina, Marco Moschini, Jeremy Yuen-Chun Teoh, et al.
Minerva Urology and Nephrology|December 18, 2025
HUGO™ RAS for radical nephroureterectomy: a new platform facing an old challengeAndrea Mari, Simone Albisinni, Roberto Contieri, et al.
European Urology|August 1, 2024
Re: Jeremy Yuen-Chun Teoh, Cheung-Hing Cheng, Chiu-Fung Tsang, et al. Transurethral En Bloc Resection Versus Standard Resection of Bladder Tumour: A Randomised, Multicentre, Phase 3 Trial. Eur Urol. 2024;86:103-111Francesco Montorsi, Pietro Scilipoti, Alessandro Viti, et al.
The Prostate|January 26, 2018
Accuracy of standardized 12-core template biopsies versus non-standardized biopsies for detection of Epstein Grade 5 prostate cancer regarding the histology of the prostatectomy specimenChristoph Würnschimmel, Pietro Grande, Marco Moschini, et al.
The Journal of Urology|September 14, 2021
Contemporary Outcomes of Patients With Nonmuscle-Invasive Bladder Cancer Treated with Bacillus Calmette-Guérin: Implications for Clinical Trial Design. LetterFrancesco Montorsi, Marco Moschini, Andrea Necchi, et al.
Cancers|September 28, 2023
The Association between Lymph Node Dissection and Survival in Lymph Node-Negative Upper Urinary Tract Urothelial CancerAleksander Ślusarczyk, Piotr Zapała, Tomasz Piecha, et al.
Pageof 56